Adverse reactions of Abrocitinib

Most common adverse events (≥1% with Cibinqo 100 mg) are nasopharyngitis, nausea, headache, herpes simplex, increased blood creatine  phosphokinase, dizziness, urinary tract infection, fatigue, acne, vomiting,  impetigo, oropharyngeal pain, hypertension, influenza, gastroenteritis, and  dermatitis contact.

Most common adverse reactions (≥1% with Cibinqo 200 mg and greater  than Cibinqo 100 mg) are nausea, headache, herpes simplex, increased  blood creatine kinase, dizziness, urinary tract infection, acne, vomiting,  gastroenteritis, upper abdominal pain, abdominal discomfort, herpes zoster,  and thrombocytopenia.

from FDA，2023.12